Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder

Articles

Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire DisorderIntroduction: Flibanserin treatment increases sexual desire and satisfying sexual events while decreasing distress in certain women diagnosed with acquired, generalized hypoactive sexual desire disorder (HSDD). Additional aspects of sexual function and the time course of response have…

Flibanserin for premenopausal hypoactive sexual desire disorder: Pooled analysis of clinical trials

Articles

Flibanserin for premenopausal hypoactive sexual desire disorder: Pooled analysis of clinical trialsBackground: Flibanserin, a 5-hydroxytryptamine 5-HT 1A  agonist and 5-HT 2A  antagonist, is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This post hoc analysis assessed pooled efficacy and safety data for flibanserin in premenopausal women with HSDD.…

Effects of alcohol administered with flibanserin in healthy premenopausal women: A randomized, double-blind, single-dose crossover study

Articles

Effects of alcohol administered with flibanserin in healthy premenopausal women: A randomized, double-blind, single-dose crossover studyIntroduction: Flibanserin is approved in the United States and Canada for the treatment of hypoactive sexual desire disorder in premenopausal women. Aim: The purpose of this trial was to evaluate the safety of concomitant administration of flibanserin with alcohol. Methods:…

Safety and tolerability of evening ethanol consumption and bedtime administration of flibanserin in healthy premenopausal female subjects

Articles

Safety and tolerability of evening ethanol consumption and bedtime administration of flibanserin in healthy premenopausal female subjectsIntroduction: Flibanserin, a treatment for hypoactive sexual desire disorder, carries warnings for increased risk of severe hypotension and syncope when used with alcohol. However, these warnings are not informed by studies that used flibanserin’s recommended bedtime dosing because previous…

Effects of timing of flibanserin administration relative to alcohol intake in healthy premenopausal women: A randomized, double-blind, crossover study

Articles

Effects of timing of flibanserin administration relative to alcohol intake in healthy premenopausal women: A randomized, double-blind, crossover studyIntroduction: Flibanserin is approved in the United States and Canada for the treatment of acquired, generalized, hypoactive sexual desire disorder in premenopausal women. Sedation-related side effects are among the most prevalent adverse events. Although infrequent, hypotension and…

Next-day residual effects of flibanserin on simulated driving performance in premenopausal women

Articles

Next-day residual effects of flibanserin on simulated driving performance in premenopausal womenObjective: The objective of this study was to determine the next-day residual effects of acute and steady-state nighttime dosing of flibanserin on simulated driving performance and cognitive function in healthy premenopausal women. Methods: In this randomized, double-blind, placebo-controlled, four-way crossover study, 72 subjects were…

Flibanserin for hypoactive sexual desire disorder: an open-label safety study

Articles

Flibanserin for hypoactive sexual desire disorder: an open-label safety studyBackground: To evaluate the safety of flibanserin in premenopausal and naturally postmenopausal women with hypoactive sexual desire disorder (HSDD) in an open-label extension (OLE) study. Aim: To examine the safety and tolerability of flibanserin 100 mg once daily at bedtime in the treatment of premenopausal and…

Open-label extension study of flibanserin in women with hypoactive sexual desire disorder

Articles

Open-label extension study of flibanserin in women with hypoactive sexual desire disorderIntroduction: Hypoactive Sexual Desire Disorder (HSDD) is a common form of Female Sexual Dysfunction characterized by low sexual desire that causes distress or interpersonal difficulty. Aim: This 52-week open-label extension study aimed to assess the safety and tolerability of flibanserin, a postsynaptic 5-HT(1A) agonist/5-HT(2A)…

Efficacy of flibanserin in women with hypoactive sexual desire disorder: Results from the BEGONIA trial

Articles

Efficacy of flibanserin in women with hypoactive sexual desire disorder: Results from the BEGONIA trialIntroduction: Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked distress or interpersonal difficulty. Aim: The aim of this study was to assess the efficacy and safety of the 5-HT1A agonist/5-HT2A antagonist flibanserin in premenopausal women…